FDA Combination Products Policy and Guidance Changes
Combination products—combinations of drugs, biologics, or devices that are physically, chemically, or otherwise produced as a single entity, such as prefilled syringes, metered dose inhalers, or drug-eluting stents—have become important healthcare tools in the last decade. Regulations and guidances affecting these products have been promulgated since the final GMP rule covering them was finalized in […]